These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34336831)

  • 1. CBFB-MYH11 Fusion Sequesters RUNX1 in Cytoplasm to Prevent DNMT3A Recruitment to Target Genes in AML.
    Liu P; Liu JP; Sun SJ; Gao Y; Ai Y; Chen X; Sun Y; Zhou M; Liu Y; Xiong Y; Yuan HX
    Front Cell Dev Biol; 2021; 9():675424. PubMed ID: 34336831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.
    Hyde RK; Zhao L; Alemu L; Liu PP
    Leukemia; 2015 Aug; 29(8):1771-8. PubMed ID: 25742748
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhen T; Kwon EM; Zhao L; Hsu J; Hyde RK; Lu Y; Alemu L; Speck NA; Liu PP
    Blood; 2017 Nov; 130(22):2431-2442. PubMed ID: 29018080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein.
    Day RB; Hickman JA; Xu Z; Katerndahl CD; Ferraro F; Ramakrishnan SM; Erdmann-Gilmore P; Sprung RW; Mi Y; Townsend RR; Miller CA; Ley TJ
    J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38061017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
    Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
    Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
    Biernacki MA; Foster KA; Woodward KB; Coon ME; Cummings C; Cunningham TM; Dossa RG; Brault M; Stokke J; Olsen TM; Gardner K; Estey E; Meshinchi S; Rongvaux A; Bleakley M
    J Clin Invest; 2020 Oct; 130(10):5127-5141. PubMed ID: 32831296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.
    Ishikawa Y; Kawashima N; Atsuta Y; Sugiura I; Sawa M; Dobashi N; Yokoyama H; Doki N; Tomita A; Kiguchi T; Koh S; Kanamori H; Iriyama N; Kohno A; Moriuchi Y; Asada N; Hirano D; Togitani K; Sakura T; Hagihara M; Tomikawa T; Yokoyama Y; Asou N; Ohtake S; Matsumura I; Miyazaki Y; Naoe T; Kiyoi H
    Blood Adv; 2020 Jan; 4(1):66-75. PubMed ID: 31899799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.
    Hyde RK; Kamikubo Y; Anderson S; Kirby M; Alemu L; Zhao L; Liu PP
    Blood; 2010 Feb; 115(7):1433-43. PubMed ID: 20007544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.
    Zhen T; Cao Y; Ren G; Zhao L; Hyde RK; Lopez G; Feng D; Alemu L; Zhao K; Liu PP
    Blood; 2020 Nov; 136(21):2373-2385. PubMed ID: 32929473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.
    Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP
    Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical study of
    Sepúlveda-Robles O; Jiménez-Hernández E; Domínguez-Catzín V; Gómez-Flores E; Martín-Trejo JA; Flores-Lujano J; Torres-Nava JR; Núñez-Enríquez JC; De Ita M; Medina-Sanson A; Mata-Rocha M; Morales-Castillo BA; Bravata-Alcántara JC; Nájera-Cortés AS; Sánchez-Escobar N; Peñaloza-Gonzalez JG; Espinosa-Elizondo RM; Flores-Villegas LV; Amador-Sanchez R; Orozco-Ruiz D; Pérez-Saldívar ML; Velázquez-Aviña MM; Merino-Pasaye LE; Solís-Labastida KA; González-Ávila AI; Santillán-Juárez JD; Bekker-Méndez VC; Jiménez-Morales S; Rangel-López A; Rosas-Vargas H; Mejía-Aranguré JM
    Front Pediatr; 2022; 10():946690. PubMed ID: 36452349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core binding factor genes and human leukemia.
    Hart SM; Foroni L
    Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits.
    Park TS; Lee ST; Song J; Lee KA; Lee JH; Kim J; Lee HJ; Han JH; Kim JK; Cho SR; Choi JR
    Cancer Genet Cytogenet; 2009 Mar; 189(2):87-92. PubMed ID: 19215788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.
    Opatz S; Polzer H; Herold T; Konstandin NP; Ksienzyk B; Zellmeier E; Vosberg S; Graf A; Krebs S; Blum H; Hopfner KP; Kakadia PM; Schneider S; Dufour A; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
    Blood; 2013 Sep; 122(10):1761-9. PubMed ID: 23878140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
    Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP
    Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
    Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
    Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of a new method for screening of CBFB-MYH11 fusion gene in acute myeloid leukemia and its value in clinical use].
    Chen C; Li ZP; Lu QY; Liu ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1077-81. PubMed ID: 23114122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating Factor.
    Abe A; Yamamoto Y; Katsumi A; Yamamoto H; Okamoto A; Inaguma Y; Iriyama C; Tokuda M; Okamoto M; Emi N; Tomita A
    Cytogenet Genome Res; 2020; 160(5):255-263. PubMed ID: 32544910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of the inv(16) fusion gene CBFB-MYH11.
    Kundu M; Liu PP
    Curr Opin Hematol; 2001 Jul; 8(4):201-5. PubMed ID: 11561156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22).
    Kurata K; Yamamoto K; Okazaki Y; Noguchi Y; Matsui K; Matsumoto H; Inui Y; Yakushijin K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Minami H
    Cancer Genet; 2020 Feb; 241():72-76. PubMed ID: 31353165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.